Tag Archives | cancer vaccines immunotherapy

Biotech Breakdown Leg #2: Another Nasty 4% Hit

Nowhere to Hide in Another 4% Correction 8/25/15 Futures Look Promising at 11p EDT; NIKKEI 225 UP 4.8% Today’s market reached epic proportions of volatility and extremes exacerbated by a DOW opening “flash crash” off 1100 points that distorted faith in market mechanics. Several long time market experts opined that the distortions and panic today […]

Continue Reading 0

Biotech Breakdown: Seeking Relief Today

At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218 —- Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349 Biotech Breakdown: Relief Today Or Another Head Fake? Biotech stocks are trying to hold the May lows with the IBB at $342 but now at $349. […]

Continue Reading 0

FED Rallies Market But Biotech Stocks Are Lagging…Update-1

Update-1 Stealth End of Month Rally Stops Biotech Slide IBB up 3.4% In July and up 1% on Last Day Stocks roared out of the box on Friday but could not hold and ended flat. NASDAQ Up 2.3% for July. Most biotech stocks were green and momentum players came back in to support their favorites: BLUE, JUNO, KITE, […]

Continue Reading 0

Biotech Bull Market Rolls On in a Volatile Q2 2015: XBI Up 12.4%

Dealmaking and Fast Money Fuel Biotechs Q2 2015 Review Despite a major down trend at the end of April and the recent sell-off, the sector outperformed in Q2 of 2015. The S&P was down 1% and flat YTD. The XBI Biotech ETF continues to be the sector ETF leader up 12.41% compared to 5% for the […]

Continue Reading 0

Biotech Stocks Lose Momentum with Greece Crisis; Blockbuster Immunotherapy Deal

Biotech Stocks in Broad Sell-Off The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%. The sector, as tracked by IBB, is still up 18.87% YTD after […]

Continue Reading 0